FDA Approves Expanded Use of Nivolumab for Lung Cancer October 9, 2015December 14, 2022 Matthew Tontonoz
FDA Approves PD-1 Immunotherapy for Most Common Type of Lung Cancer October 2, 2015December 14, 2022 Matthew Tontonoz
In a First, FDA Approves Immunotherapy Combination for Advanced Melanoma October 1, 2015December 14, 2022 Matthew Tontonoz
New Study: Vaccine Holds Promise in Treating Cervical Pre-Cancer September 25, 2015January 26, 2023 Matthew Tontonoz
Clinton and Cuomo Applaud the Work of CRI Scientists at Annual Awards Dinner September 23, 2015December 14, 2022 Matthew Tontonoz